Considering the critical role of inflammation in both the onset and progression of MS, there is a pressing need for further research to investigate how physical exercise, particularly during early and/or relapsing–remitting phases, influences inflammatory markers such as adiponectin in MS. Here, ADIPOQ is linked to myeloid sarcoma.